Clinical Trial Update: The Possible Efficacy and Safety of Lansoprazole Co-administration With Neoadjuvant Chemotherapy in Women With Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial investigating the efficacy and safety of co-administering lansoprazole with neoadjuvant chemotherapy in women with breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lansoprazole (Lansoprazole)

Snippet

Sponsor: Tanta University | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED